 |
|
 |
 |

Home > Company Index > Drugs > Drugs - Generic > Taro Pharmaceutical Industries Ltd.
 |
Taro Pharmaceutical Industries Ltd. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Small-cap stocks: Healthcare favored on earnings strength Jul 31 2001 09:43 AM PDT
Taro files for 5.75 mln share offering Jul 25 2001 02:07 PM PDT
Investor Profile: Dater's venture fund turns defensive Jul 24 2001 09:03 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Generic drugs are Taro's future. Taro Pharmaceutical Industries makes generic and proprietary drugs to treat dermatologic conditions, epilepsy, and other diseases. The company specializes in topical corticosteroids with such products as hydrocortisone valerate cream and ointment and clobetasol proprionate solution, among other products. It also makes teril carbamazepine tablets that are equivalent to Tegretol, Novartis' epilepsy treatment. Other drugs include clomipramine hydrochloride, an antidepressant; acetazolamide, a diuretic; and Warfarin Sodium Tablets, for the treatment of heart disease and stroke prevention.
COMPETITION |
 |
Medicis Pharmaceutical Corporation (MRX)
Novartis AG (NVS)
Pfizer Inc (PFE)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 103.80
1-Yr. Sales Growth: 23.9%
Employees: 500
Revenue per employee: $207,600.00
KEY PEOPLE |
 |
Aaron Levitt
CEO
Kevin Connelly
CFO
CONTACT INFO |
 |
32 Maskit St.
Herzlia, Pitauch 46120, Israel
Phone: 972-997-1800
Fax: 972-995-7443
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |